> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Neuroblastoma NDA
- URL: https://www.fdaweb.com/panel-to-discuss-neuroblastoma-nda/
- Published: 2023-08-16T12:00:00.000Z
- Updated: 2026-09-14T18:51:07.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155111

*Federal Register* notice: FDA is announcing a 10/4 Oncologic Drugs Advisory Committee meeting. Panel members are scheduled to discuss a World Meds NDA for eflornithine tablets, indicated for reducing the risk of relapse in pediatric patients with high-risk neuroblastoma who have completed multiagent, multimodality therapy. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-08-16/pdf/2023-17510.pdf?ref=fdaweb.com).